JPM-Byte 2025

Scaling Biology 003: Sam Rodriques, Co-Founder and CEO at FutureHouse

BioByte 101: de novo antibody design, measuring how fast your brain is aging, enhancing GWAS, commentary on trial results, and more

BioByte 100: integrating biological complexity into AI, scaling connectomics to the human brain, deep brain stimulation for spinal cord injury, ESM Cambrian launch

BioByte 099: Ferroptosis across disease, adipose retains epigenetic memory, Cephalopod-inspired drug delivery, and predicting RNA 3D structures

BioByte 098: big challenges in protein-design, OpenAI takes clinical trials, how non-neural cells remember and predicting psychiatric disease from social media.

BioByte 097: Drivers of biological progress, immunogenicity in gene therapy & a vision for AI scientists

BioByte 096: brain shuttles for antibody delivery, immune privilege in the brain, DNA data storage, clinical translation of spatial biology

BioByte 095: Using autrotrophs for food production, the future of computational drug discovery, calls for a CRISPR revolution, a proteogenomic pipeline for neoantigen discovery

BioByte 094: industry consortium for benchmarking, evaluating protein competitions, multimodal atlas for Alzheimer's, automated organelle tracking, promise of a new HAE treatment

BioByte 093: A big week for AI, GLP-1s program the neurovascular landscape , an AAV primer and LLCs in biotech

BioByte 092: reversing diabetes with cell therapy, the effect of mislocalization of proteins within a cell, DNA methylation in the brain, NIH-wide exposome research centre launch